Literature DB >> 26495874

Prevalence, awareness, characteristics, and health outcomes associated with COPD at-risk status among adults in Japan.

Hisamitsu Omori1, Daisuke Yoshimoto2, Maya Kumar3, Amir Goren3.   

Abstract

OBJECTIVES: We examined the prevalence of chronic obstructive pulmonary disease (COPD) diagnosed and at-risk status, and public awareness of COPD among adults in Japan, as well as respondent characteristics and health outcomes compared with controls.
METHODS: Regression models used 2012 National Health and Wellness Survey in Japan data to compare COPD-diagnosed, at-risk, and healthy adults (aged ≥18) on demographics, health behaviors, health-related quality of life (HRQoL), productivity and healthcare resource use.
RESULTS: Among n = 29,978 respondents, diagnosed COPD prevalence was 0.9%; 26.9% were at-risk. Relative to controls, those at-risk and diagnosed with COPD had significantly greater healthcare resource use, with lower productivity and HRQoL. Fewer than 20% of respondents were aware of COPD.
CONCLUSIONS: Over 25% of adult Japanese respondents were at-risk for COPD and had health outcomes impairments relative to controls. Efforts to increase awareness among the general public are needed.

Entities:  

Keywords:  At-risk status; Japan; awareness; chronic obstructive pulmonary disease; health-related quality of life; prevalence; productivity loss; resource use

Mesh:

Year:  2015        PMID: 26495874     DOI: 10.1586/14737167.2016.1104250

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  4 in total

1.  Lack of awareness towards smoking-related health risks, symptoms related to COPD, and attitudinal factors concerning smoking: an Internet-based survey conducted in a random sample of the Danish general population.

Authors:  Melina Gade Sikjær; Ole Hilberg; Andreas Fløe; Jens Dollerup; Anders Løkke
Journal:  Eur Clin Respir J       Date:  2018-08-14

2.  Characteristics and health burden of the undiagnosed population at risk of chronic obstructive pulmonary disease in China.

Authors:  Marco Koch; Thomas Butt; Wudong Guo; Xue Li; Yirong Chen; Diana Tan; Gordon G Liu
Journal:  BMC Public Health       Date:  2019-12-23       Impact factor: 3.295

3.  Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.

Authors:  Masakazu Ichinose; Yasushi Fukushima; Yoshikazu Inoue; Osamu Hataji; Gary T Ferguson; Klaus F Rabe; Nobuya Hayashi; Hiroshi Okada; Mami Takikawa; Eric Bourne; Shaila Ballal; Kiernan DeAngelis; Magnus Aurivillius; Paul Dorinsky; Colin Reisner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-12-23

4.  Geographical Differences and Their Associated Factors in Chronic Obstructive Pulmonary Disease Mortality in Japan: An Ecological Study Using Nationwide Data.

Authors:  Tasuku Okui; Jinsang Park
Journal:  Int J Environ Res Public Health       Date:  2021-12-20       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.